Effects of Cyproterone Compound Combined with flutamide in females severe acne
Phase 2
- Conditions
- Acne vulgaris.Acne vulgaris
- Registration Number
- IRCT201302164310N8
- Lead Sponsor
- Ardabil University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Inclusion criterion: females that had severe acne.
Exclusion criteria: pregnancy; breastfeeding; liver disease; receiving anti acne drugs; OCP & spironolacton in last 2 months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in acne leasions. Timepoint: onset of study & 60th,120th,180th of study. Method of measurement: lesions counting.
- Secondary Outcome Measures
Name Time Method Patients`satisfaction. Timepoint: Every two months. Method of measurement: Questionnaire.